Stem cell-derived intestinal organoids: a novel modality for IBD.

Cheng-Mei Tian1,2, Mei-Feng Yang3, Hao-Ming Xu4

  • 1Department of Gastroenterology, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, 518020, Guangdong, China.

Cell Death Discovery
|July 21, 2023
PubMed
Summary

Stem cell-derived intestinal organoids offer a revolutionary 3D in vitro model. These organoids mimic human intestine structure and function, advancing drug screening, disease modeling, and regenerative medicine for inflammatory bowel disease (IBD).

Related Concept Videos